Haugen M, Heier HE, Nissen-Meyer LSH(2026) Is Norway's transfusion service ethical and sustainable? Tidsskr Nor Laegeforen, 146(2) DOI 10.4045/tidsskr.25.0692, PubMed 41670313
Kildal AB, Ueland T, Mirlashari MR, Nissen-Meyer LS, Granerud BK, Dyrhol-Riise AM, Tonby K, Holten AR, Heggelund L, Müller KE, Tveita A, Bøe S, Fagerhol MK, Hetland G, Holter JC, Norwegian SARS-CoV-2 study group(2026) Serial blood serum measurements of calprotectin and deoxyribonuclease in COVID-19 patients during hospitalization and recovery until one year: a prospective, multicenter, observational study BMC Infect Dis(in press) DOI 10.1186/s12879-026-12939-x, PubMed 41772481
Haugen M, Nissen-Meyer LSH, Strand TA, Magnussen K(2025) The effect of plasma donation frequency on total serum protein, immunoglobulin G and donor safety: A non-inferiority randomized controlled trial Vox Sang, 120(12), 1205-1215 DOI 10.1111/vox.70105, PubMed 40876898
Get in touch
Contact
Group Leader Lise Sofie Haug Nissen-Meyer Department of immunology and transfusion medicine Tel: +47 +22117828 / 48284525 E-mail: lisoha@ous-hf.no